We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Thermo Fisher Scientific Inc | NYSE:TMO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 15.10 | 2.61% | 593.03 | 594.025 | 578.81 | 580.17 | 1,328,834 | 01:00:00 |
From May 2023 to May 2024
By Dean Seal
Thermo Fisher has reduced its revenue and adjusted earnings outlook for 2023 after market conditions weakened further in the third quarter.
The Waltham, Mass.-based scientific-equipment company now expects adjusted earnings, which strip out one-time items, of $21.50 a share, down from its prior forecast for $22.28 to $22.72 a share.
Revenue is now projected to come in at $42.7 billion, a drop from previous guidance for $43.4 billion to $44 billion.
Core organic revenue, which strips out Covid-19 testing revenue and the impacts of acquisitions and foreign currency translation, is expected to rise 1%.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
October 25, 2023 06:44 ET (10:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Thermo Fisher Scientific Chart |
1 Month Thermo Fisher Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
